Xueyan Zhang

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Tianqing Chu, Runbo Zhong, Hua Zhong et al. · Journal of Thoracic Oncology · 2021 · 216 citations · Full text

Phase 1B, Advanced Nsclc, Sintilimab Plus Anlotinib +6

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

Baohui Han, Bo Jin, Tianqing Chu et al. · International Journal of Cancer · 2017 · 152 citations · Full text

ccNET: Database of co-expression networks with functional modules for diploid and polyploid <i>Gossypium</i>

Qi You, Wenying Xu, Kang Zhang et al. · Nucleic Acids Research · 2016 · 100 citations · Full text

Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy

Jun Lü, Hua Zhong, Tianqing Chu et al. · European Respiratory Journal · 2018 · 94 citations

Small-Sized Titanium Dioxide Nanoparticles Mediate Immune Toxicity in Rat Pulmonary Alveolar Macrophages &lt;I&gt;In Vivo&lt;/I&gt;

Ran Liu, Xueyan Zhang, Yuepu Pu et al. · Journal of Nanoscience and Nanotechnology · 2010 · 90 citations

Nanoparticles, Acute Lung Injury, Engineering +19